D5BH:F:F-Xtrackers - MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 68.87

Change

-0.34 (-0.49)%

Market Cap

USD 0.36B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.03 (-0.10%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.09 (-0.18%)

USD 115.04B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.01 (+0.05%)

USD 83.57B
SXR8:F iShares Core S&P 500 UCITS ETF..

-2.75 (-0.55%)

USD 80.45B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.01 (+0.01%)

USD 76.57B
EUNL:F iShares Core MSCI World UCITS ..

-0.25 (-0.28%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-1.60 (-0.70%)

USD 58.19B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 56.18B
VUSA:F Vanguard Funds Public Limited ..

-0.51 (-0.57%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.46 (-0.52%)

USD 49.95B

ETFs Containing D5BH:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.89% 49% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.89% 46% F 52% F
Trailing 12 Months  
Capital Gain 7.16% 59% D- 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.16% 58% F 58% F
Trailing 5 Years  
Capital Gain 44.64% 72% C 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.64% 71% C- 57% F
Average Annual (5 Year Horizon)  
Capital Gain 9.60% 83% B 76% C+
Dividend Return 9.60% 82% B 70% C-
Total Return N/A 15% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 18.09% 27% F 61% D-
Risk Adjusted Return 53.05% 82% B 85% B
Market Capitalization 0.36B 54% F 46% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.